spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ethinyl estradiol 

 HSMN NewsFeed - 17 Dec 2019
Prasco launches NuvaRing(R) (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 17 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2016
Allergan Announces Launch of TAYTULLA(TM) (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 23 Sep 2016
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2016
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR(TM) (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jul 2016
CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Apr 2016
AbbVie Announces Real-World Data with VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA(R) (dasabuvir tablets) from Large German Hepatitis C-Registry
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2015
AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval in Japan for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Jan 2015
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Sep 2013
Amneal Pharmaceuticals to Acquire Four Generic Products
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 9 May 2013
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Mar 2013
FDA Approves New Drug Application (NDA) for Teva’s Quartette(TM) (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2012
Teva Receives FDA Acceptance of Its New Drug Application for Quartette(TM) (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 May 2012
New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to Combination Oral Contraceptive in a Comparator Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 18 Apr 2011
Warner Chilcott Announces Plans to Restructure Western European Operations
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2010
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Sep 2010
Watson's Generic Yasmin(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Jun 2010
Agile Therapeutics Secures $45M in Series B Funding to Progress Lead Contraceptive Patch, AG200-15, Through NDA Filing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2010
Watson Files FDA Application for Generic LoSeasonique(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 1 Apr 2009
Teva Announces Approval of Generic Yaz Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Dec 2008
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2008
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2008
Sosei Announces Completion of Phase III Trial for NorLevo(R)
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 16 May 2008
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 21 Apr 2008
Watson Files FDA Application for Generic YASMIN(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 16 Apr 2008
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2008
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Biopharmaceuticals Litigation
 HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 7 Nov 2007
Watson Files FDA Application for Generic YAZ(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Oct 2007
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Oct 2007
Barr's Generic Version of Estrostep(R) Fe Tablets Approved
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2007
Watson Files Application for Generic FEMCON(R) Fe
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 15 Aug 2007
Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
Biopharmaceuticals Generics
 HSMN NewsFeed - 30 Jul 2007
Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2007
Agile Therapeutics Appoints Dr. Marie Foegh as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2007
Women's Menstrual Cycles Can Be Seasonal with SEASONALE(TM): First Extended-Cycle Oral Contraceptive Approved by Health Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2007
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jun 2007
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 22 May 2007
FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
Bayer HealthCare and Intendis Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Apr 2007
Abbott Agrees With World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir)
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 29 Jan 2007
FDA Approves New Indication for YAZ(R) to Treat Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Dec 2006
First and Only Chewable Birth Control Pill Now Available
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Oct 2006
FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2006
Barr Announces Warner Chilcott Waives Exclusive License for OVCON(R) 35
Biopharmaceuticals Generics
 HSMN NewsFeed - 7 Sep 2006
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
Biopharmaceuticals Generics
 HSMN NewsFeed - 7 Sep 2006
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jun 2006
Wyeth Receives Approvable Letter From the FDA for Lybrel
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 May 2006
FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral Contraceptive Company's Second Proprietary Extended-Cycle OC to be Available in July
Return to NewsFeed  

 Additional items found! 64

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 64 additional stories matching:
ethinyl estradiol
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.